Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07228273. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Development of a Diagnostic Kit for FLT3-ITD in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01141673. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
ClinicalTrials.gov study NCT01020734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00354276. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03760523. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival
ClinicalTrials.gov study NCT03549351. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02674763. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04021368. IPD Sharing: NO. Countries: 2. Publications: 0.
CER-1236 in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06834282. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic
ClinicalTrials.gov study NCT06083129. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06709131. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets
ClinicalTrials.gov study NCT05215639. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT04951778. IPD Sharing: YES. Countries: 2. Publications: 0.
DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hematopoietic Cell Transplantation, the DR. DREAM Trial
ClinicalTrials.gov study NCT06492707. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Study of HC-7366 for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06285890. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04342962. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05574608. IPD Sharing: NO. Countries: 1. Publications: 0.
CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01768897. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Entrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53 Mutated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05396859. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01246622. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.